The Effects of Pre-Loaded Betaine Supplementation on Thermoregulation and Exercise Metabolism in the Heat
1 other identifier
interventional
14
1 country
1
Brief Summary
This will be a double blind, placebo-controlled, randomized, counterbalanced, crossover study designed to assess the impact of preloaded betaine supplementation on thermoregulation and exercise metabolism in the heat. The study, outlined in Figure 7 and described in detail below, will consist of seven total visits to the Institute of Sports Science and Medicine (ISSM) or Sandels laboratories at Florida State University, two of which will be experimental visits. On the first visit, participants will be informed as to the details of the study before giving their oral and written informed consent (Appendix A). Thereafter, anthropometrics will be measured and participants will complete an incremental exercise test on an electronically-braked cycle ergometer to volitional exhaustion to determine peak oxygen consumption (VO2 peak). Days 1-6 participants will consume a full dosage of supplementation, whereas day 0 and 7 participants will consume half a dose of the supplement, with the last dosage being consumed 60 minutes prior to experimental visits, days 7 and 21. On days 2 and 4, familiarization trials will be completed to standardize training loads and to reduce any potential learning effect. These visits will be implemented in the heat. On day 7, participants will complete the first experimental trial described in detail below. Afterwards, participants will enter a seven day washout period 167 before crossing over to the second supplemental condition on day 14. On days 16 and 18, participants will undergo the same familiarization trials as they did on days 2 and 4. On day 21, participants will complete their second experimental trial. Each experimental trial will be separated by 14 days. This study will be approved by the Florida State University Insitutional Review Board (Appendix B).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Jan 2020
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2019
CompletedStudy Start
First participant enrolled
January 21, 2020
CompletedFirst Posted
Study publicly available on registry
October 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2023
CompletedMarch 13, 2024
March 1, 2024
3.6 years
July 8, 2019
March 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Fluid Compartment Volumes (Bioelectrical Impedance Spectrocopy)
Intracellular fluid volume (L), extracellular fluid volume (L), plasma volume (L), total body water (L)
pre and post 7 days of supplementation
Thermoregulation (core temperature pills, skin temperature sensors)
Core temperature (Degrees C), skin temperature (Degrees C)
pre and post 7 days of supplementation & minutes 0, 15, 30, 45, 60, 75, and 90 during the experimental visit
Thermoregulation (enzyme linked immunoassays)
serum expression of heat shock protein 72 and plasma lipopolysaccharide concentrations
7 days of supplementation & minutes 0, 30, 60, and 90 during the experimental visit
Thermoregulation (thermal sensation scale)
Subjective self-reported assessment of perceived thermal sensation (arbitrary units)
minutes 0, 15, 30, 45, 60, 75, and 90 during the experimental visit
Secondary Outcomes (2)
Exercise Metabolism and Performance (heart rate)
minutes 0, 15, 30, 45, 60, 75, and 90 during the experimental visit
Exercise Metabolism and Performance (Oxygen Consumption)
minutes 0-5, 25-30, and 55-60 during the experimental visit
Study Arms (3)
Betaine
EXPERIMENTALAim 1: To evaluate the impact of preloaded betaine supplementation on fluid compartments in male athletes aged 18-45 years old. Aim 2: To determine the degree to which preloading with betaine impacts heat tolerance relative to placebo in male athletes aged 18-45 years old. Aim 3: To determine the degree to which preloading with betaine impacts exercise metabolism and performance in the heat relative to placebo in male athletes aged 18-45 years old.
Placebo
EXPERIMENTALAim 1: To evaluate the impact of preloaded betaine supplementation on fluid compartments in male athletes aged 18-45 years old. Aim 2: To determine the degree to which preloading with betaine impacts heat tolerance relative to placebo in male athletes aged 18-45 years old. Aim 3: To determine the degree to which preloading with betaine impacts exercise metabolism and performance in the heat relative to placebo in male athletes aged 18-45 years old.
NOW Foods Big 6
EXPERIMENTALAim 1: To evaluate the impact of preloaded betaine supplementation on fluid compartments in male athletes aged 18-45 years old. Aim 2: To determine the degree to which preloading with betaine impacts heat tolerance relative to placebo in male athletes aged 18-45 years old. Aim 3: To determine the degree to which preloading with betaine impacts exercise metabolism and performance in the heat relative to placebo in male athletes aged 18-45 years old.
Interventions
50 mg/kg Betaine consumed twice daily for 7 days.
1 level scoop (\~18 g) of NOW Foods BCAA Big 6, consumed once per day for 7 days.
50 mg/kg Placebo consumed twice daily for 7 days.
Eligibility Criteria
You may qualify if:
- Sex: male
- Age: 18-45 yr
- Trained male cyclists: ≥ 3 yr cycling experience
- Participants' VO2 peak \> 50.0 ml·kg·min-1
You may not qualify if:
- Sex: female
- Age: \< 18 yr or \> 45 yr
- Cigarette smoking: current cigarette smoker or those who quit within the previous 6 months
- Participants' VO2 peak \< 50.0 ml·kg·min-1
- Participants consuming supplements known to impact hydration status and exercise performance
- Participants known to have sickle cell trait or disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Florida State Universitylead
- NOW Foodscollaborator
Study Sites (1)
Institute of Sport Sciences and Medicine at Florida State University
Tallahassee, Florida, 32304, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Miachael Ormsbee, PhD
Florida State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 8, 2019
First Posted
October 14, 2020
Study Start
January 21, 2020
Primary Completion
August 15, 2023
Study Completion
December 15, 2023
Last Updated
March 13, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share